Literature DB >> 16050880

Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study.

Ira B Wilson1, William H Rogers, Hong Chang, Dana Gelb Safran.   

Abstract

OBJECTIVE: To report rates of cost-related skipping of medications and other treatments, assess correlates of skipping, examine changes in skipping between 1998 and 2000, and identify factors associated with changes in skipping. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional and longitudinal analyses of surveys of a probability sample of Medicare beneficiaries in 13 states in 1998 and 2000. MAIN OUTCOME MEASURE: Self-reported rates of skipping medications and other treatments.
RESULTS: Cost-related skipping rates increased from 9.5% in 1998 to 13.1% in 2000. In separate multivariable models using 1998 and 2000 data, higher out-of-pocket costs, lower physician-patient relationship quality, low income, and lacking prescription drug coverage were associated with more skipping (P<.05 for all). Better physical and mental health, and greater age were associated with less skipping (P<.05). HMO membership was not associated with higher rates of skipping in 1998 (P=.84), but was in 2000 (P<.0004). In longitudinal analyses, increased medication costs and HMO membership were associated with the observed increase cost-related skipping between 1998 and 2000.
CONCLUSIONS: Cost-related skipping was associated with several factors, including drug coverage, poverty, poor health, and physician-patient relationship quality. The important role of physician-patient relationships in cost-related skipping has not been shown previously. Physicians should be aware of these risk factors for cost-related skipping, and initiate dialogue about problems paying for prescription medications and other treatments.

Entities:  

Mesh:

Year:  2005        PMID: 16050880      PMCID: PMC1490185          DOI: 10.1111/j.1525-1497.2005.0128.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  19 in total

1.  Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.

Authors:  L A Lillard; J Rogowski; R Kington
Journal:  Med Care       Date:  1999-09       Impact factor: 2.983

2.  Growing differences between Medicare beneficiaries with and without drug coverage.

Authors:  J A Poisal; L Murray
Journal:  Health Aff (Millwood)       Date:  2001 Mar-Apr       Impact factor: 6.301

3.  Drug coverage and drug purchases by Medicare beneficiaries with hypertension.

Authors:  J Blustein
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

4.  Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?

Authors:  A S Adams; S B Soumerai; D Ross-Degnan
Journal:  Health Aff (Millwood)       Date:  2001 Jan-Feb       Impact factor: 6.301

5.  Tracking health care costs.

Authors:  Bradley C Strunk; Paul B Ginsburg; Jon R Gabel
Journal:  Health Aff (Millwood)       Date:  2001       Impact factor: 6.301

6.  The Primary Care Assessment Survey: tests of data quality and measurement performance.

Authors:  D G Safran; M Kosinski; A R Tarlov; W H Rogers; D H Taira; N Lieberman; J E Ware
Journal:  Med Care       Date:  1998-05       Impact factor: 2.983

7.  The quality of physician-patient relationships. Patients' experiences 1996-1999.

Authors:  J Murphy; H Chang; J E Montgomery; W H Rogers; D G Safran
Journal:  J Fam Pract       Date:  2001-02       Impact factor: 0.493

8.  Primary care quality in the Medicare Program: comparing the performance of Medicare health maintenance organizations and traditional fee-for-service medicare.

Authors:  Dana Gelb Safran; Ira B Wilson; William H Rogers; Jana E Montgomery; Hong Chang
Journal:  Arch Intern Med       Date:  2002-04-08

9.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

10.  Self-restriction of medications due to cost in seniors without prescription coverage.

Authors:  M A Steinman; L P Sands; K E Covinsky
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

View more
  28 in total

1.  Adherence, placebo effects, and mortality.

Authors:  Ira B Wilson
Journal:  J Gen Intern Med       Date:  2010-12       Impact factor: 5.128

2.  The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes.

Authors:  Quyen Ngo-Metzger; Dara H Sorkin; John Billimek; Sheldon Greenfield; Sherrie H Kaplan
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

3.  Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.

Authors:  Walid F Gellad; Jennifer S Haas; Dana Gelb Safran
Journal:  J Gen Intern Med       Date:  2007-09-20       Impact factor: 5.128

4.  Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach.

Authors:  Kara Zivin; Scott Ratliff; Michele M Heisler; Kenneth M Langa; John D Piette
Journal:  Value Health       Date:  2010-01-08       Impact factor: 5.725

5.  Identifying patients with cost-related medication non-adherence: a big-data approach.

Authors:  James X Zhang; David O Meltzer
Journal:  J Med Econ       Date:  2016-04-15       Impact factor: 2.448

6.  Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

Authors:  Huseyin Naci; Stephen B Soumerai; Dennis Ross-Degnan; Fang Zhang; Becky A Briesacher; Jerry H Gurwitz; Jeanne M Madden
Journal:  Med Care       Date:  2014-11       Impact factor: 2.983

7.  Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature.

Authors:  Rahul Shenolikar; Amanda Schofield Bruno; Michael Eaddy; Christopher Cantrell
Journal:  Am Health Drug Benefits       Date:  2011-11

8.  Awareness of pharmaceutical cost-assistance programs among inner-city seniors.

Authors:  Alex D Federman; Dana Gelb Safran; Salomeh Keyhani; Helen Cole; Ethan A Halm; Albert L Siu
Journal:  Am J Geriatr Pharmacother       Date:  2009-04

9.  Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults.

Authors:  Elizabeth Holt; Cara Joyce; Adriana Dornelles; Donald Morisky; Larry S Webber; Paul Muntner; Marie Krousel-Wood
Journal:  J Am Geriatr Soc       Date:  2013-03-25       Impact factor: 5.562

10.  An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control.

Authors:  Irene V Blair; John F Steiner; Rebecca Hanratty; David W Price; Diane L Fairclough; Stacie L Daugherty; Michael Bronsert; David J Magid; Edward P Havranek
Journal:  J Gen Intern Med       Date:  2014-02-19       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.